Novo Nordisk Forecast, price target & analysts
Novo Nordisk Target price 2025 - Analyst rating & recommendation
Novo Nordisk Classifications & Recommendation:
Novo Nordisk Price Target
| Target Price | DKK747.11 |
| Price | DKK421.25 |
| Potential |
77.35%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Novo Nordisk 2026 .
The average Novo Nordisk target price is DKK747.11.
This is
77.35%
register free of charge
DKK1,150.00
173.00%
register free of charge
DKK405.00
3.86%
register free of charge
|
|
| A rating was issued by 34 analysts: 23 Analysts recommend Novo Nordisk to buy, 8 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of
77.35%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion DKK | 290.40 | 347.19 |
| 25.03% | 19.55% | |
| EBITDA Margin | 50.95% | 49.98% |
| 6.23% | 1.90% | |
| Net Margin | 34.67% | 34.20% |
| 2.89% | 1.35% |
27 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share DKK | 22.67 | 26.74 |
| 21.42% | 17.95% | |
| P/E | 15.75 | |
| EV/Sales | 5.61 |
19 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Current Novo Nordisk Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Apr 07 2025 |
| REDBURN ATLANTIC |
Locked
➜
Locked
|
Locked | Apr 06 2025 |
| NYKREDIT MARKETS |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| ODDO BHF |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Mar 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Apr 07 2025 |
|
Locked
REDBURN ATLANTIC:
Locked
➜
Locked
|
Apr 06 2025 |
|
Locked
NYKREDIT MARKETS:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
|
Locked
ODDO BHF:
Locked
➜
Locked
|
Mar 13 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Mar 09 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
